Replies to post #2359 on Gilead Sciences Inc (GILD)

[LasNubes]

Their latest, pangenotypic HCV treatment has hit the street. Their drug reps have started pushing the new drug and should drive prescriptions towards GILD as a first to market on the pangenotypic paradigm.